D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Netflix
NFLX
|
+$427M |
| 2 |
NXP Semiconductors
NXPI
|
+$267M |
| 3 |
Medtronic
MDT
|
+$245M |
| 4 |
Gilead Sciences
GILD
|
+$244M |
| 5 |
Hewlett Packard
HPE
|
+$213M |
Top Sells
| 1 |
Amazon
AMZN
|
+$406M |
| 2 |
CVS Health
CVS
|
+$381M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$307M |
| 5 |
VMW
VMware, Inc
VMW
|
+$268M |
Sector Composition
| 1 | Technology | 14.04% |
| 2 | Healthcare | 13.47% |
| 3 | Financials | 11.87% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Industrials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Arrowhead Research
ARWR
$3.76B
| $101K | ﹤0.01% |
+65,342
| New | +$101K |
|
2377
Halozyme
HALO
$8.87B
| $100K | ﹤0.01% |
10,112
-60,279
| -86% | -$596K |
|
2378
Noodles & Co
NDLS
$30.9M
| $97K | ﹤0.01% |
23,778
-5,276
| -18% | -$21.5K |
|
|
FIT
2379
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $95K | ﹤0.01% |
+13,011
| New | +$95K |
|
2380
Frontline
FRO
$5.01B
| $94K | ﹤0.01% |
13,238
-22,693
| -63% | -$161K |
|
2381
VEON
VEON
$3.8B
| $94K | ﹤0.01% |
981
-101
| -9% | -$9.68K |
|
|
EXK
2382
Endeavour Silver
EXK
$1.74B
| $91K | ﹤0.01% |
+25,917
| New | +$91K |
|
2383
Diana Shipping
DSX
$207M
| $89K | ﹤0.01% |
42,383
+26,857
| +173% | +$56.4K |
|
2384
Gold Resource Corp
GORO
$107M
| $89K | ﹤0.01% |
+20,478
| New | +$89K |
|
|
EACQW
2385
DELISTED
Easterly Acquisition Corp.
EACQW
| $88K | ﹤0.01% |
+250,000
| New | +$88K |
|
|
VIRX
2386
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $87K | ﹤0.01% |
691
+223
| +48% | +$28.1K |
|
|
FTR
2387
DELISTED
Frontier Communications Corp.
FTR
| $83K | ﹤0.01% |
1,647
-141,744
| -99% | -$7.14M |
|
|
REXX
2388
DELISTED
Rex Energy Corporation
REXX
| $83K | ﹤0.01% |
17,525
-18,711
| -52% | -$88.6K |
|
2389
LendingClub
LC
$1.89B
| $82K | ﹤0.01% |
3,124
-2,396
| -43% | -$62.9K |
|
2390
Alaunos Therapeutics
TCRT
$4.83M
| $82K | ﹤0.01% |
103
-54
| -34% | -$43K |
|
2391
Enphase Energy
ENPH
$4.96B
| $81K | ﹤0.01% |
+80,209
| New | +$81K |
|
|
XRM
2392
DELISTED
Xerium Technologies Inc (new)
XRM
| $80K | ﹤0.01% |
14,156
-227
| -2% | -$1.28K |
|
|
BBG
2393
DELISTED
Bill Barrett Corp
BBG
| $75K | ﹤0.01% |
10,716
-272,383
| -96% | -$1.91M |
|
2394
Gerdau
GGB
$6.31B
| $74K | ﹤0.01% |
+29,509
| New | +$74K |
|
2395
Mr. Cooper
COOP
$13.8B
| $69K | ﹤0.01% |
+3,689
| New | +$69K |
|
2396
Uranium Energy
UEC
$5.37B
| $69K | ﹤0.01% |
61,837
+50,662
| +453% | +$56.5K |
|
2397
Medallion Financial
MFIN
$250M
| $65K | ﹤0.01% |
+21,454
| New | +$65K |
|
2398
Tidewater
TDW
$2.92B
| $63K | ﹤0.01% |
+577
| New | +$63K |
|
|
ANDAR
2399
DELISTED
Andina Acquisition Corp. II Right
ANDAR
| $61K | ﹤0.01% |
156,700
| – | – |
|
2400
Ambev
ABEV
$34.6B
| $60K | ﹤0.01% |
12,311
-270,321
| -96% | -$1.32M |
|